Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells

Author： Bokvist K.   Hoy M.   Buschard K.   Holst J.J.   Thomsen M.K.   Gromada J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.386, Iss.1, 1999-12, pp. : 105-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nateglinide produces superior mealtime glucose regulation to repaglinide in healthy subjects

By  

Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

A review of clinical experience with the prandial glucose regulator, repaglinide, in the treatment of Type 2 diabetes

By Moses R.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1455-1467

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic islet responsiveness to d-glucose after repeated administration of repaglinide

By Laghmich A.   Ladriere L.   Malaisse-Lagae F.   Malaisse W.J.  

European Journal of Pharmacology, Vol. 348, Iss. 2, 1998-05 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite

Repaglinide Preserves Nutrient-Stimulated Biosynthetic Activity in Rat Pancreatic Islets

By Vinambres C.   Villanueva-Penacarrillo M.L.   Valverde I.   Malaisse W.J.  

Pharmacological Research, Vol. 34, Iss. 1, 1996-07 ,pp. : 83-85

Academic Press

Access to resources Recommend Favorite

Postprandial glucose control - the promise of nateglinide

By  

Inpharma, Vol. 1, Iss. 1309, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite